BER Stock Overview
Bioerg Spólka Akcyjna engages in the retail trade of food and chemical products for humans and animals in Poland.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Bioerg Spólka Akcyjna Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.14 |
| 52 Week High | zł0.29 |
| 52 Week Low | zł0.13 |
| Beta | 1.02 |
| 1 Month Change | 0% |
| 3 Month Change | -5.57% |
| 1 Year Change | -17.63% |
| 3 Year Change | 133.62% |
| 5 Year Change | 50.56% |
| Change since IPO | -80.64% |
Recent News & Updates
Shareholder Returns
| BER | PL Biotechs | PL Market | |
|---|---|---|---|
| 7D | 0% | 1.9% | -1.2% |
| 1Y | -17.6% | -16.4% | 24.4% |
Return vs Industry: BER underperformed the Polish Biotechs industry which returned -8.8% over the past year.
Return vs Market: BER underperformed the Polish Market which returned 24.7% over the past year.
Price Volatility
| BER volatility | |
|---|---|
| BER Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 5.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in PL Market | 9.6% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: BER has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BER's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 1 | Piotr Klomfas | www.bioerg.pl |
Bioerg Spólka Akcyjna engages in the retail trade of food and chemical products for humans and animals in Poland. The company undertakes technical maintenance of industrial installations; repairs of installations, devices, and industrial fitting, as well as repair and service of machines. It is also involved in servicing of overhead cranes, cranes, and scales; producing chemical apparatus, and maintenance of technical efficiency.
Bioerg Spólka Akcyjna Fundamentals Summary
| BER fundamental statistics | |
|---|---|
| Market cap | zł13.78m |
| Earnings (TTM) | -zł66.00k |
| Revenue (TTM) | zł299.00k |
46.1x
P/S Ratio-208.8x
P/E RatioIs BER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BER income statement (TTM) | |
|---|---|
| Revenue | zł299.00k |
| Cost of Revenue | zł29.00k |
| Gross Profit | zł270.00k |
| Other Expenses | zł336.00k |
| Earnings | -zł66.00k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 10, 2023
| Earnings per share (EPS) | -0.00065 |
| Gross Margin | 90.30% |
| Net Profit Margin | -22.07% |
| Debt/Equity Ratio | 123.6% |
How did BER perform over the long term?
See historical performance and comparison